MODIFICATION
A -- 2018 NIAID Omnibus Broad Agency Announcement - Amendment 7
- Notice Date
- 8/31/2018
- Notice Type
- Modification/Amendment
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Office of Acquisitions, 5601 Fishers Lane, 3rd Floor, MSC 9821, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- HHS-NIH-NIAID-BAA2018
- Point of Contact
- Julie Catherine Rodriguez, Phone: 301-402-2284, George Kennedy, Phone: 240-669-5170
- E-Mail Address
-
julie.rodriguez@nih.gov, kennedyg@mail.nih.gov
(julie.rodriguez@nih.gov, kennedyg@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Attachment: HHS-NIH-NIAID-BAA2018, Amendment 1 (Revised 08-31-2018) Amendment 6 - To revise Section 3.2 solicitation HHS-NIH-NIAID-BAA2018, and respond to questions received in response to Research Area 003: Collaborative Influenza Vaccine Innovation Centers (CIVICs). National Institute of Allergy & Infectious Diseases (NIAID) 2018 Omnibus Broad Agency Announcement - HHS-NIH-NIAID-BAA2018 Activity Log: 1. Solicitation Issuance : 06/01/2018 2. Amendment No.1 Issuance : 07/03/2018 - Purpose of Amendment 1: To add RESEARCH AREA 003, "Collaborative Influenza Vaccine Innovation Centers (CIVICs)" to the 2018 Omnibus Broad Agency Announcement - Included Attachments: Revised solicitation: "HHS-NIH-NIAID-BAA2018 - Amendment One" 3. Amendment No.2 Issuance : 07/03/2018 - Purpose of Amendment 2: To provide responses to questions received regarding Research Areas 001 and 002 of this solicitation. 4. Amendment No.3 Issuance : 07/20/2018 - Purpose of Amendment 3: This amendment is applicable to RESEARCH AREA 003, "Collaborative Influenza Vaccine Innovation Centers (CIVICs)". This amendment provides a Government point of contact for organizations wishing to advertise their interest in collaborating with other interested organizations. Michael C. Finn, M.B.A., Chief Contracting Officer Phone: (240) 669-5125 Email: finnm@niaid.nih.gov 5. Amendment No.4 Issuance : 07/24/2018 - Purpose of Amendment 4: To provide responses to questions received regarding Research Areas 001 and 002 of this solicitation. 6. Amendment No.5 Issuance : 08/02/2018 - Purpose of Amendment 5: To revise solicitation HHS-NIH-NIAID-BAA2018; clarifying that the PHS Human Subjects and Clinical Trials Information Form is NOT included in the Technical Proposal page limit, and providing updated hyperlinks within the solicitation. - Included Attachments: Revised solicitation: "HHS-NIH-NIAID-BAA2018, Amendment 1 (Revised 08-02-2018)" 7. Amendment No.6 Issuance: 08/31/2018 - Purpose of Amendment 6: This amendment is applicable to RESEARCH AREA 003, "Collaborative Influenza Vaccine Innovation Centers (CIVICs)". The purpose of this amendment is to revise Section 3.2 of solicitation HHS-NIH-NIAID-BAA2018, and provide responses to questions received in response to Research Area 003. - Included Attachments: Revised solicitation: "HHS-NIH-NIAID-BAA2018, Amendment 1 (Revised 08-31-2018)"
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIAID/HHS-NIH-NIAID-BAA2018/listing.html)
- Record
- SN05066565-W 20180902/180831230914-9047055d12340ef54e035aadc2b14375 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |